Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer

Triple negative breast cancer (TNBC) is currently the only major breast tumor subtype without effective targeted therapy and, as a consequence, usually presents a poor outcome. Due to its more aggressive phenotype, there is an urgent clinical need to identify novel biomarkers that discriminate indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Fernando, Nakata, Asuka, Gotoh, Noriko, Fujita, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Genética 2020
Materias:
Human and Medical Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198019/
https://www.ncbi.nlm.nih.gov/pubmed/31487369
http://dx.doi.org/10.1590/1678-4685-GMB-2018-0269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198019/
https://www.ncbi.nlm.nih.gov/pubmed/31487369
http://dx.doi.org/10.1590/1678-4685-GMB-2018-0269

Ejemplares similares